Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has informed the exchanges about a conference call scheduled for investors and analysts on Wednesday, August 13, 2025 at 6:15 PM IST. The call will discuss the company's unaudited financial results for Q1FY26, which will be declared on the same day. The management team will include the Executive Chairman Vivek Sharma, Managing Director Dr. V Prasada Raju, CEO Dr. Sudhir Kumar Singh, CFO Himanshu Agarwal, and Head of IR Cyndrella Carvalho. International dial-in numbers have been provided for participants from India, Singapore, Hong Kong, USA, and UK.
This is a routine intimation about an upcoming earnings call and does not contain any new financial data. Shareholders should watch the Q1FY26 results announcement on August 13, 2025, for actual performance numbers that could influence the stock price.